✦ LIBER ✦

Discovery of (−)-7-Methyl-2- exo -[3′-(6-[ 18 F]fluoropyridin-2-yl)-5′-pyridinyl]-7-azabicyclo[2.2.1]heptane, a Radiolabeled Antagonist for Cerebral Nicotinic Acetylcholine Receptor (α4β2-nAChR) with Optimal Positron Emission Tomography Imaging Properties

✍ Scribed by Gao, Yongjun; Kuwabara, Hiroto; Spivak, Charles E.; Xiao, Yingxian; Kellar, Kenneth; Ravert, Hayden T.; Kumar, Anil; Alexander, Mohab; Hilton, John; Wong, Dean F.; Dannals, Robert F.; Horti, Andrew G.

Book ID: 127348634
Publisher: American Chemical Society
Year: 2008
Tongue: English
Weight: 303 KB
Volume: 51
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm800323d

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and Nicotinic Acetylcholine Re

Synthesis and Nicotinic Acetylcholine Receptor Binding Properties of exo -2-(2‘-Fluoro-5‘-pyridinyl)-7-azabicyclo- [2.2.1]heptane: A New Positron Emission Tomography Ligand for Nicotinic Receptors

✍ Liang, Feng; Navarro, Hernán A.; Abraham, Philip; Kotian, Pravin; Ding, Yu-Shin; 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 103 KB

ChemInform Abstract: Synthesis and Nicot

ChemInform Abstract: Synthesis and Nicotinic Acetylcholine Receptor Binding Properties of exo-2-(2′-Fluoro-5′-pyridinyl)-7-azabicyclo(2.2.1)heptane: A New Positron Emission Tomography Ligand for Nicotinic Receptors.

✍ F. LIANG; H. A. NAVARRO; P. ABRAHAM; P. KOTIAN; Y.-S. DING; J. FOWLER; N. VOLKOW 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 2 views

Radiosynthesis of 2-exo-(2′-[18F]Fluoro-

Radiosynthesis of 2-exo-(2′-[18F]Fluoro-3′-(4-fluorophenyl)-pyridin-5′-yl)-7-azabicyclo[2.2.1]heptane ([18F]F2PhEP), a potent epibatidine-based radioligand for nicotinic acetylcholine receptor PET imaging

✍ Gaëlle Roger; Françoise Hinnen; Héric Valette; Wadad Saba; Michel Bottlaender; F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 189 KB

2-exo-(2 0 -Fluoro-3 0 -(4-fluorophenyl)-pyridin-5 0 -yl)-7-azabicyclo[2.2.1]heptane (F 2 PhEP), a novel, epibatidine-based, a4b2-selective nicotinic acetylcholine receptor antagonist of low toxicity, as well as the corresponding N-Boc-protected chloro-and bromo derivatives as precursors for labelli